As a critical tumor suppressor, downregulation or mutation of p53 may impair the cell’s ability to arrest the cell cycle in response to DNA damage, thereby potentially increasing the risk of uncontrolled cell proliferation or malignancy. This evidence concerns the gene TP53 and neoplasm.